Galderma Group AG (GALD)

Switzerland
Currency in CHF
78.55
+0.20(+0.26%)
Closed·
GALD Scorecard
Full Analysis
Net income is expected to grow this year
Fair Value
Day's Range
77.0078.75
52 wk Range
63.25119.60
Key Statistics
Edit
Bid/Ask
77.80 / 80.50
Prev. Close
78.35
Open
78.5
Day's Range
77-78.75
52 wk Range
63.25-119.6
Volume
271.11K
Average Volume (3m)
699.56K
1-Year Change
24.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GALD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
104.23
Upside
+32.70%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Galderma Group AG Company Profile

Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Compare GALD to Peers and Sector

Metrics to compare
GALD
Peers
Sector
Relationship
P/E Ratio
98.6x−0.1x−0.5x
PEG Ratio
0.200.000.00
Price/Book
2.9x1.3x2.6x
Price / LTM Sales
5.1x1.7x2.9x
Upside (Analyst Target)
35.8%82.7%66.2%
Fair Value Upside
Unlock11.0%10.3%Unlock

Analyst Ratings

8 Buy
2 Hold
1 Sell
Ratings:
11 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 104.23
(+32.70% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.97%
Dividend Yield
-
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
-
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Galderma (GALD) Stock Price Today?

The Galderma stock price today is 78.55

What Stock Exchange Does Galderma Trade On?

Galderma is listed and trades on the Switzerland stock exchange.

What Is the Stock Symbol for Galderma?

The stock symbol for Galderma is "GALD."

What Is the Galderma Market Cap?

As of today, Galderma market cap is 18.65B.

What is Galderma Earnings Per Share?

The Galderma EPS is 0.97.

From a Technical Analysis Perspective, Is GALD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.